C. Houghton

Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma

I. Pavord, R. Hancox, M. Weatherall, 2020, European Respiratory Journal.

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

R. Hancox, Philippa Williams, M. Weatherall, 2019, The Lancet.

Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.

I. Pavord, R. Hancox, M. Weatherall, 2019, The New England journal of medicine.

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.

I. Pavord, R. Hancox, M. Weatherall, 2020, The Lancet. Respiratory medicine.

Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials

I. Pavord, R. Hancox, M. Weatherall, 2022, BMJ Open Respiratory Research.